10-K.A – Page 12 – China Stock Advice

ONP [Orient Paper] 10-K/A: x o o o o o Large accelerated

[x o o o o o Large accelerated filer o Accelerated filer o Non-accelerated filer x Smaller reporting company o x The aggregate market value of the voting and non-voting common stock of the issuer held by non-affiliates as of June 30, 2009 was approximately $11,820,387 (6,566,882 shares of common stock held by non-affiliates) based upon a closing price of] [SARBANES-OXLEY ACT OF 2002 I, Zhenyong Liu, certify that: 1. I have reviewed this annual report on Form 10-K/A of Orient Paper, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which] [SARBANES-OXLEY ACT OF 2002 I, Winston C. Yen, certify that: 1. I have reviewed this annual report on Form 10-K/A of Orient Paper, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (1) (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Dated: March 23, 2011 Zhenyong Liu Chief Executive Officer] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (1) (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Dated: March 23,2011 Winston C. Yen Chief Financial Officer (principal financial and accounting officer )]

By info| 2016-03-20T00:54:22+00:00 March 23rd, 2011|Categories: Chinese Stocks, ONP, Webplus ver|Tags: 0001358190, 10-K.A, 2011-03-23, 2670, CONVERTED PAPER and PAPERBOARD PRODS (NO CONTAINERS/BOXES), ONP|0 Comments

ONP [Orient Paper] 10-K/A: (Original Filing)

[Note x Yes o o Large accelerated filer o Accelerated filer o Non-accelerated filer o (Do not check if a smaller reporting company) x Smaller reporting company o Yes x Note. The aggregate market value of the voting and non-voting common stock of the issuer held by non-affiliates as of March 24, 2009 was approximately $3,494,073 (20,553,371 shares of common] [SARBANES-OXLEY ACT OF 2002 I, Zhenyong Liu, certify that: 1. I have reviewed this annual report on Form 10-K/A of Orient Paper, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which] [SARBANES-OXLEY ACT OF 2002 I, Winston C. Yen, certify that: 1. I have reviewed this annual report on Form 10-K/A of Orient Paper, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (1) (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Dated: March 23, 2011 Zhenyong Liu Chief Executive Officer] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (1) (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Dated: March 23,2011 Winston C. Yen Chief Financial Officer (principal financial and accounting officer )]

By info| 2016-03-20T00:55:58+00:00 March 23rd, 2011|Categories: Chinese Stocks, ONP, SEC Original|Tags: 0001358190, 10-K.A, 2011-03-23, 2670, CONVERTED PAPER and PAPERBOARD PRODS (NO CONTAINERS/BOXES), ONP|0 Comments

CPHI [CHINA PHARMAS,] 10-K/A: (Original Filing)

[FORM 10-K/A (Amendment No. 1) x For the fiscal year ended December 31, 2010 or ¨ For the transition period from _________ to _____________ 001-34471 China Pharma Holdings, Inc. Delaware 73-1564807 (State or other jurisdiction of incorporation or organization) (IRS Employer Identification No.) Second Floor, No. 17, Jinpan Road Haikou, Hainan Province, China 570216 (011) 86 898-6681-1730 Common Stock, par] [CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We consent to the incorporation by reference in Registration Statement No. 333-164049 on Form S-3 and Registration Statement No. 333-141734 Post-Effective Amendment No. 1 to Form SB-2 on Form S-3 of our report dated March 2, 2011 relating to the consolidated financial statements of China Pharma Holdings, Inc. and subsidiaries appearing in this] [CERTIFICATION (Section 302 of the Sarbanes-Oxley Act of 2002) I, Zhilin Li, certify that: 1. I have reviewed this Amendment No. 1 to Annual Report on Form 10-K of China Pharma Holdings, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make] [CERTIFICATION (Section 302 of the Sarbanes-Oxley Act of 2002) I, Frank Waung, certify that: 1. 2. 3. 4. a. b. c. d. 5. a. b.] [CERTIFICATION (Section 906 of the Sarbanes-Oxley Act of 2002) (1) (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Zhilin Li EX-32.1 8 cphi10kaex321123110.htm] [CERTIFICATION (Section 906 of the Sarbanes-Oxley Act of 2002) (1) (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Frank Waung Chief Financial Officer (principal financial officer and principal accounting officer) EX-32.2 9 cphi10kaex322123110.htm]

By info| 2016-03-03T19:39:04+00:00 March 17th, 2011|Categories: Chinese Stocks, CPHI, SEC Original|Tags: 0001106644, 10-K.A, 2011-03-17, 2834, CPHI, PHARMACEUTICAL PREPARATIONS|0 Comments

CPHI [CHINA PHARMAS,] 10-K/A: FORM 10-K/A (Amendment No. 1) x For the

[FORM 10-K/A (Amendment No. 1) x For the fiscal year ended December 31, 2010 or ¨ For the transition period from _________ to _____________ 001-34471 China Pharma Holdings, Inc. Delaware 73-1564807 (State or other jurisdiction of incorporation or organization) (IRS Employer Identification No.) Second Floor, No. 17, Jinpan Road Haikou, Hainan Province, China 570216 (011) 86 898-6681-1730 Common Stock, par] [CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We consent to the incorporation by reference in Registration Statement No. 333-164049 on Form S-3 and Registration Statement No. 333-141734 Post-Effective Amendment No. 1 to Form SB-2 on Form S-3 of our report dated March 2, 2011 relating to the consolidated financial statements of China Pharma Holdings, Inc. and subsidiaries appearing in this] [CERTIFICATION (Section 302 of the Sarbanes-Oxley Act of 2002) I, Zhilin Li, certify that: 1. I have reviewed this Amendment No. 1 to Annual Report on Form 10-K of China Pharma Holdings, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make] [CERTIFICATION (Section 302 of the Sarbanes-Oxley Act of 2002) I, Frank Waung, certify that: 1. 2. 3. 4. a. b. c. d. 5. a. b.] [CERTIFICATION (Section 906 of the Sarbanes-Oxley Act of 2002) (1) (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Zhilin Li EX-32.1 8 cphi10kaex321123110.htm] [CERTIFICATION (Section 906 of the Sarbanes-Oxley Act of 2002) (1) (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Frank Waung Chief Financial Officer (principal financial officer and principal accounting officer) EX-32.2 9 cphi10kaex322123110.htm]

By info| 2016-03-03T19:40:39+00:00 March 17th, 2011|Categories: Chinese Stocks, CPHI, Webplus ver|Tags: 0001106644, 10-K.A, 2011-03-17, 2834, CPHI, PHARMACEUTICAL PREPARATIONS|0 Comments

CPHI [CHINA PHARMAS,] 10-K/A: (Original Filing)

[FORM 10-K/A (Amendment No. 1) x For the fiscal year ended December 31, 2010 or For the transition period from _________ to _____________ 001-34471 China Pharmas, Delaware 73-1564807 (State or other jurisdiction oforporation or organization) (IRS Employer Identification No.) Second Floor, No. 17, Jinpan Road Haikou, Hainan Province, China 570216] [CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM Wensent to theorporation by reference in Registration Statement No. 333-164049 on Form S-3 and Registration Statement No. 333-141734 Post-Effective Amendment No. 1 to Form SB-2 on Form S-3 of our reportted March 2, 2011 relating to thensolidated financial statements of China Pharmas, and subsidiaries appearing in this Annual] [CERTIFICATION (Section 302 of therbanes-Oxley Act of 2002) I, Zhilin Li, certify that: 1. I have reviewed this Amendment No. 1 to Annual Report on Form 10-K of China Pharmas,; 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to] [CERTIFICATION (Section 302 of therbanes-Oxley Act of 2002) I, Frank Waung, certify that: 1. 2. 3. 4. a. b. c. d. 5. a. b. Frank Waung Chief Financial Officer (principal financial officer and principal accounting officer) cphi10kaex312123110.htm 7 EX-31.2] [CERTIFICATION (Section 906 of therbanes-Oxley Act of 2002) (1) (2) The informationntained in the Report fairly presents, inl material respects, the financialndition and results of operations of thempany. Zhilin Li cphi10kaex321123110.htm 8 EX-32.1] [CERTIFICATION (Section 906 of therbanes-Oxley Act of 2002) (1) (2) The informationntained in the Report fairly presents, inl material respects, the financialndition and results of operations of thempany. Frank Waung Chief Financial Officer (principal financial officer and principal accounting officer) cphi10kaex322123110.htm 9 EX-32.2]

By info| 2016-02-07T23:01:45+00:00 March 17th, 2011|Categories: Chinese Stocks, CPHI, SEC Original|Tags: 0001106644, 10-K.A, 2011-03-17, 2834, CPHI, PHARMACEUTICAL PREPARATIONS|0 Comments

CPHI [CHINA PHARMAS,] 10-K/A: FORM 10-K/A (Amendment No. 1) x For the

[FORM 10-K/A (Amendment No. 1) x For the fiscal year ended December 31, 2010 or For the transition period from _________ to _____________ 001-34471 China Pharmas, Delaware 73-1564807 (State or other jurisdiction oforporation or organization) (IRS Employer Identification No.) Second Floor, No. 17, Jinpan Road Haikou, Hainan Province, China 570216] [CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM Wensent to theorporation by reference in Registration Statement No. 333-164049 on Form S-3 and Registration Statement No. 333-141734 Post-Effective Amendment No. 1 to Form SB-2 on Form S-3 of our reportted March 2, 2011 relating to thensolidated financial statements of China Pharmas, and subsidiaries appearing in this Annual] [CERTIFICATION (Section 302 of therbanes-Oxley Act of 2002) I, Zhilin Li, certify that: 1. I have reviewed this Amendment No. 1 to Annual Report on Form 10-K of China Pharmas,; 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to] [CERTIFICATION (Section 302 of therbanes-Oxley Act of 2002) I, Frank Waung, certify that: 1. 2. 3. 4. a. b. c. d. 5. a. b. Frank Waung Chief Financial Officer (principal financial officer and principal accounting officer) cphi10kaex312123110.htm 7 EX-31.2] [CERTIFICATION (Section 906 of therbanes-Oxley Act of 2002) (1) (2) The informationntained in the Report fairly presents, inl material respects, the financialndition and results of operations of thempany. Zhilin Li cphi10kaex321123110.htm 8 EX-32.1] [CERTIFICATION (Section 906 of therbanes-Oxley Act of 2002) (1) (2) The informationntained in the Report fairly presents, inl material respects, the financialndition and results of operations of thempany. Frank Waung Chief Financial Officer (principal financial officer and principal accounting officer) cphi10kaex322123110.htm 9 EX-32.2]

By info| 2016-02-07T23:02:37+00:00 March 17th, 2011|Categories: Chinese Stocks, CPHI, Webplus ver|Tags: 0001106644, 10-K.A, 2011-03-17, 2834, CPHI, PHARMACEUTICAL PREPARATIONS|0 Comments

CGA [China Green Agriculture] 10-K/A: (Original Filing)

[] [Contract No. LHJN-002-08 Processing Contract for the Complete Equipment Installation of Drip Fertilizer Party A: Shaanxi Techteam Jinong Humic Acid Products Co., Ltd. Party B: Xi’an Kingtone Information Co., Ltd NOW, THEREFORE, in consideration of the Contract Law of People’s Republic of China as well as relevant regulations and provisions, and through mutual friendly negotiation, both Parties hereto enter into] [Contract for Phase II Extension of Integrated & Wireless Pipeline Control System of Shaanxi Techteam Jinong Humic Acid Products Co., Ltd Contract No.: LHJN-08-08 Signing at: Xi’an Party A: Shaanxi Techteam Jinong Humic Acid Products Co., Ltd Party B: Xi’an Kingtone Information Co., Ltd NOW, THEREFORE, in consideration of the mutual promises, covenants as well as agreements made by the] [CERTIFICATION I, Tao Li, certify that: 1. I have reviewed this Amendment No. 1 on Form 10-K/A of China Green Agriculture, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such] [CERTIFICATION I, Ken Ren, certify that: 1. I have reviewed this Amendment No. 1 on Form 10-K/A of China Green Agriculture, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Dated: December 30, 2010 Tao Li President and Chief Executive Officer Ken Ren Chief Financial Officer (principal financial officer and principle accounting officer) EX-32.1 6]

By info| 2016-03-19T01:51:16+00:00 December 30th, 2010|Categories: CGA, Chinese Stocks, SEC Original|Tags: 0000857949, 10-K.A, 2010-12-30, 2870, AGRICULTURE CHEMICALS, CGA|0 Comments

CGA [China Green Agriculture] 10-K/A:

[] [Contract No. LHJN-002-08 Processing Contract for the Complete Equipment Installation of Drip Fertilizer Party A: Shaanxi Techteam Jinong Humic Acid Products Co., Ltd. Party B: Xi’an Kingtone Information Co., Ltd NOW, THEREFORE, in consideration of the Contract Law of People’s Republic of China as well as relevant regulations and provisions, and through mutual friendly negotiation, both Parties hereto enter into] [Contract for Phase II Extension of Integrated & Wireless Pipeline Control System of Shaanxi Techteam Jinong Humic Acid Products Co., Ltd Contract No.: LHJN-08-08 Signing at: Xi’an Party A: Shaanxi Techteam Jinong Humic Acid Products Co., Ltd Party B: Xi’an Kingtone Information Co., Ltd NOW, THEREFORE, in consideration of the mutual promises, covenants as well as agreements made by the] [CERTIFICATION I, Tao Li, certify that: 1. I have reviewed this Amendment No. 1 on Form 10-K/A of China Green Agriculture, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such] [CERTIFICATION I, Ken Ren, certify that: 1. I have reviewed this Amendment No. 1 on Form 10-K/A of China Green Agriculture, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Dated: December 30, 2010 Tao Li President and Chief Executive Officer Ken Ren Chief Financial Officer (principal financial officer and principle accounting officer) EX-32.1 6]

By info| 2016-03-19T01:52:29+00:00 December 30th, 2010|Categories: CGA, Chinese Stocks, Webplus ver|Tags: 0000857949, 10-K.A, 2010-12-30, 2870, AGRICULTURE CHEMICALS, CGA|0 Comments

DHRM [Dehaier Medical Systems] 10-K/A: (Original Filing)

[] [CERTIFICATION I, Ping Chen, certify that: (1) I have reviewed this Annual Report on Form 10-K/A of Dehaier Medical Systems Limited; (2) Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements] [CERTIFICATION I, Zheng (Rita) Liu, certify that: (1) I have reviewed this Annual Report on Form 10-K/A of Dehaier Medical Systems Limited; (2) Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 2. The information contained in the Report fairly presents, in all material respects, the consolidated financial condition and results of operations of the Company. December 10, 2010 Ping Chen Chief Executive Officer] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 2. The information contained in the Report fairly presents, in all material respects, the consolidated financial condition and results of operations of the Company. December 10, 2010 Zheng (Rita) Liu Chief Financial Officer]

By info| 2016-03-25T09:13:45+00:00 December 10th, 2010|Categories: Chinese Stocks, DHRM, SEC Original|Tags: 0001474627, 10-K.A, 2010-12-10, 3841, DHRM, SURGICAL and MEDICAL INSTRUMENTS and APPARATUS|0 Comments

DHRM [Dehaier Medical Systems] 10-K/A:

[] [CERTIFICATION I, Ping Chen, certify that: (1) I have reviewed this Annual Report on Form 10-K/A of Dehaier Medical Systems Limited; (2) Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements] [CERTIFICATION I, Zheng (Rita) Liu, certify that: (1) I have reviewed this Annual Report on Form 10-K/A of Dehaier Medical Systems Limited; (2) Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 2. The information contained in the Report fairly presents, in all material respects, the consolidated financial condition and results of operations of the Company. December 10, 2010 Ping Chen Chief Executive Officer] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 2. The information contained in the Report fairly presents, in all material respects, the consolidated financial condition and results of operations of the Company. December 10, 2010 Zheng (Rita) Liu Chief Financial Officer]

By info| 2016-03-25T09:14:35+00:00 December 10th, 2010|Categories: Chinese Stocks, DHRM, Webplus ver|Tags: 0001474627, 10-K.A, 2010-12-10, 3841, DHRM, SURGICAL and MEDICAL INSTRUMENTS and APPARATUS|0 Comments